Isomerase were approached by a biotech company looking to generate analogues of a known natural product peptide/polyketide, produced by a filamentous streptomycete bacteria.

• Solution: Strain improvement, USP and DSP development alongside bioengineering


Strain improvement was carried out via rational and classical approaches, alongside fermentation optimisation and DSP development. Titres (which were initially <0.01mg/L) reached the target required by the partner (>1g/L). Bioengineering on the strain was carried out to allow production of a range of related products, by feeding different small synthetic precursors. These were fermented, isolated and supplied for further activity and property testing.

If you would like to learn more about our capabilities then please get in contact with us here.

 

novel analogues of a mixed peptide

Save
Cookies user preferences
All essential cookies are mandatory in order to allow logging in and submitting forms etc. You can choose to decline some non-essential ones.
Accept all
Decline all
Read more
Analytics
Tools used to analyze the data to measure the effectiveness of a website and to understand how it works.
Analytics
Accept
Decline